| Views | |
|---|---|
| Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | 176 |
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | 1 | 2 | 8 | 0 | 6 | 22 | 15 |
| Views | |
|---|---|
| Lokteva_Correction.pdf | 76 |
| Views | |
|---|---|
| United States | 56 |
| Canada | 25 |
| China | 7 |
| Germany | 6 |
| Vietnam | 6 |
| Brazil | 3 |
| Switzerland | 3 |
| India | 3 |
| Russia | 3 |
| Belgium | 2 |
| Views | |
|---|---|
| Ottawa | 24 |
| Houston | 11 |
| Mountain View | 6 |
| Beijing | 4 |
| Ann Arbor | 3 |
| Mumbai | 3 |
| San Francisco | 3 |
| Washington | 3 |
| White Plains | 3 |
| Baltimore | 2 |